Journal profile · Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science

Pharmaceutical Nanotechnology

ISSN 2211-7385 · eISSN 2211-7393 · Bentham

Pharmaceutical Nanotechnology: subscription journal; median 64 days to acceptance (33 articles, last 24 months); 37 articles in 2025; indexed in Scopus.

Impact factor—No published value
CAS zone—Not in the CAS Journal Ranking
CiteScore quartileQ2Pharmaceutical Science · rank 84/191 · 56th percentile
Review time64 daysMedian, submission to acceptance · 33 articles, last 24 months · Crossref
APC—No source gives fee information
Acceptance—No reports yet
Articles per year372025 · OpenAlex count
Indexed inScopusLetPub

Scope

Aims, scope and focus

Pharmaceutical Nanotechnology is published by Bentham. By OpenAlex counts of its recent articles, its largest topics are Nanoparticle-Based Drug Delivery, Advanced Drug Delivery Systems and Advancements in Transdermal Drug Delivery, together about 58.4% of its articles. Its main subfields are Pharmaceutical Science. (generated from OpenAlex topic counts and CAS ranking data)

Research area (LetPub): Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Nanoparticle-Based Drug DeliveryMaterials Science24.3%
  2. Advanced Drug Delivery SystemsPharmacology, Toxicology and Pharmaceutics21.9%
  3. Advancements in Transdermal Drug DeliveryPharmacology, Toxicology and Pharmaceutics12.2%
  4. Drug Solubulity and Delivery SystemsPharmacology, Toxicology and Pharmaceutics9.1%
  5. Nanoparticles: synthesis and applicationsMaterials Science5.4%
  6. Pharmacology and Nanomedicine ResearchPharmacology, Toxicology and Pharmaceutics3.4%
  7. Nanotechnology research and applicationsEngineering2.8%
  8. RNA Interference and Gene DeliveryBiochemistry, Genetics and Molecular Biology2.6%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Not covered

Not covered by this edition.

CAS Xinrui Journal Ranking (March 2026)Not covered

Not covered by this edition.

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

CiteScore quartiles (Scopus, June 2026 release)

SubjectQuartileRankPercentile
Pharmaceutical ScienceQ284/19156th
Biomedical EngineeringQ3193/34243rd

Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub

Database indexing

ScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

CiteScore 2026-06
3.9LetPub ·
SJR 2026-06
0.38LetPub ·
SNIP 2026-06
0.43LetPub ·
h-index
37OpenAlex ·
i10-index
168OpenAlex ·
2-year mean citedness
3.91OpenAlex ·
Share of gold OA articles
0%LetPub ·

Articles by year OpenAlex count · 630 in total · the current year is incomplete

YearArticlesOpen accessCitations
2026230885
20253701,171
20249841,048
2023676874
2022523767
2021399666

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with Crossref · to

64 daysMedian, submission to acceptance · P25–P75 47 days – 105 days

Acceptance to online
median 203 days (33 articles)
Submission to online
median 255 days
Sample
33 articles with submission and acceptance dates (160 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Subscription journalLetPub

A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.

No source has fee information yet; check the journal's website.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Before you submit

Four checks before submitting to Pharmaceutical Nanotechnology

  1. 1
    ScopeRecent output centres on Nanoparticle-Based Drug Delivery, Advanced Drug Delivery Systems.
    Check scope
  2. 2
    Article type and formatPrepare text, figures and references as the author guidelines ask.
  3. 3
    English languagePolish grammar and academic style before you submit: it lowers the risk of rejection for language and improves your chances of acceptance.
  4. 4
    Expected review time64 days · Median, submission to acceptance · 33 articles, last 24 months · Crossref
    Review data

The checks are built from this page's data.

Profile

Publication details and official links

Publisher
Bentham
ISSN
2211-7385
Electronic ISSN
2211-7393

FAQ

Frequently asked questions about Pharmaceutical Nanotechnology

How long does peer review take at Pharmaceutical Nanotechnology?

Based on the dates recorded on 33 articles published between November 2024 and November 2026 (the last 24 months), the median time from submission to acceptance is 64 days (interquartile range 47–105 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Which databases index Pharmaceutical Nanotechnology?

According to LetPub and DOAJ records, Pharmaceutical Nanotechnology is indexed in Scopus.

Is Pharmaceutical Nanotechnology open access, and what is the APC?

Pharmaceutical Nanotechnology is a subscription journal. Fee information is not available yet; check the journal's website.

Sources and updates

The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .